This report contains market size and forecasts of Genome Editing/Genome Engineering in Global, including the following market information:
Global Genome Editing/Genome Engineering Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Genome Editing/Genome Engineering market was valued at 3614.8 million in 2020 and is projected to reach US$ 5083.8 million by 2027, at a CAGR of 8.9% during the forecast period.
Publisher has surveyed the Genome Editing/Genome Engineering companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genome Editing/Genome Engineering Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Genome Editing/Genome Engineering Market Segment Percentages, By Type, 2020 (%)
CRISPR
TALEN
ZFN
China Genome Editing/Genome Engineering Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Genome Editing/Genome Engineering Market Segment Percentages, By Application, 2020 (%)
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Global Genome Editing/Genome Engineering Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Genome Editing/Genome Engineering Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Genome Editing/Genome Engineering Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Genome Editing/Genome Engineering Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated Dna Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Genome Editing/Genome Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genome Editing/Genome Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genome Editing/Genome Engineering Overall Market Size
2.1 Global Genome Editing/Genome Engineering Market Size: 2021 VS 2027
2.2 Global Genome Editing/Genome Engineering Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genome Editing/Genome Engineering Players in Global Market
3.2 Top Global Genome Editing/Genome Engineering Companies Ranked by Revenue
3.3 Global Genome Editing/Genome Engineering Revenue by Companies
3.4 Top 3 and Top 5 Genome Editing/Genome Engineering Companies in Global Market, by Revenue in 2020
3.5 Global Companies Genome Editing/Genome Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genome Editing/Genome Engineering Players in Global Market
3.6.1 List of Global Tier 1 Genome Editing/Genome Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Genome Editing/Genome Engineering Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genome Editing/Genome Engineering Market Size Markets, 2021 & 2027
4.1.2 CRISPR
4.1.3 TALEN
4.1.4 ZFN
4.2 By Type - Global Genome Editing/Genome Engineering Revenue & Forecasts
4.2.1 By Type - Global Genome Editing/Genome Engineering Revenue, 2016-2021
4.2.2 By Type - Global Genome Editing/Genome Engineering Revenue, 2022-2027
4.2.3 By Type - Global Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genome Editing/Genome Engineering Market Size, 2021 & 2027
5.1.2 Cell Line Engineering
5.1.3 Animal Genetic Engineering
5.1.4 Plant Genetic Engineering
5.2 By Application - Global Genome Editing/Genome Engineering Revenue & Forecasts
5.2.1 By Application - Global Genome Editing/Genome Engineering Revenue, 2016-2021
5.2.2 By Application - Global Genome Editing/Genome Engineering Revenue, 2022-2027
5.2.3 By Application - Global Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Genome Editing/Genome Engineering Market Size, 2021 & 2027
6.2 By Region - Global Genome Editing/Genome Engineering Revenue & Forecasts
6.2.1 By Region - Global Genome Editing/Genome Engineering Revenue, 2016-2021
6.2.2 By Region - Global Genome Editing/Genome Engineering Revenue, 2022-2027
6.2.3 By Region - Global Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Genome Editing/Genome Engineering Revenue, 2016-2027
6.3.2 US Genome Editing/Genome Engineering Market Size, 2016-2027
6.3.3 Canada Genome Editing/Genome Engineering Market Size, 2016-2027
6.3.4 Mexico Genome Editing/Genome Engineering Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Genome Editing/Genome Engineering Revenue, 2016-2027
6.4.2 Germany Genome Editing/Genome Engineering Market Size, 2016-2027
6.4.3 France Genome Editing/Genome Engineering Market Size, 2016-2027
6.4.4 U.K. Genome Editing/Genome Engineering Market Size, 2016-2027
6.4.5 Italy Genome Editing/Genome Engineering Market Size, 2016-2027
6.4.6 Russia Genome Editing/Genome Engineering Market Size, 2016-2027
6.4.7 Nordic Countries Genome Editing/Genome Engineering Market Size, 2016-2027
6.4.8 Benelux Genome Editing/Genome Engineering Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Genome Editing/Genome Engineering Revenue, 2016-2027
6.5.2 China Genome Editing/Genome Engineering Market Size, 2016-2027
6.5.3 Japan Genome Editing/Genome Engineering Market Size, 2016-2027
6.5.4 South Korea Genome Editing/Genome Engineering Market Size, 2016-2027
6.5.5 Southeast Asia Genome Editing/Genome Engineering Market Size, 2016-2027
6.5.6 India Genome Editing/Genome Engineering Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Genome Editing/Genome Engineering Revenue, 2016-2027
6.6.2 Brazil Genome Editing/Genome Engineering Market Size, 2016-2027
6.6.3 Argentina Genome Editing/Genome Engineering Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, 2016-2027
6.7.2 Turkey Genome Editing/Genome Engineering Market Size, 2016-2027
6.7.3 Israel Genome Editing/Genome Engineering Market Size, 2016-2027
6.7.4 Saudi Arabia Genome Editing/Genome Engineering Market Size, 2016-2027
6.7.5 UAE Genome Editing/Genome Engineering Market Size, 2016-2027
7 Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Major Product Offerings
7.1.4 Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.1.5 Thermo Fisher Scientific Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Genome Editing/Genome Engineering Major Product Offerings
7.2.4 Merck Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Horizon Discovery
7.3.1 Horizon Discovery Corporate Summary
7.3.2 Horizon Discovery Business Overview
7.3.3 Horizon Discovery Genome Editing/Genome Engineering Major Product Offerings
7.3.4 Horizon Discovery Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.3.5 Horizon Discovery Key News
7.4 Genscript
7.4.1 Genscript Corporate Summary
7.4.2 Genscript Business Overview
7.4.3 Genscript Genome Editing/Genome Engineering Major Product Offerings
7.4.4 Genscript Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.4.5 Genscript Key News
7.5 Sangamo Biosciences
7.5.1 Sangamo Biosciences Corporate Summary
7.5.2 Sangamo Biosciences Business Overview
7.5.3 Sangamo Biosciences Genome Editing/Genome Engineering Major Product Offerings
7.5.4 Sangamo Biosciences Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.5.5 Sangamo Biosciences Key News
7.6 Integrated Dna Technologies
7.6.1 Integrated Dna Technologies Corporate Summary
7.6.2 Integrated Dna Technologies Business Overview
7.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Major Product Offerings
7.6.4 Integrated Dna Technologies Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.6.5 Integrated Dna Technologies Key News
7.7 Lonza
7.7.1 Lonza Corporate Summary
7.7.2 Lonza Business Overview
7.7.3 Lonza Genome Editing/Genome Engineering Major Product Offerings
7.4.4 Lonza Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.7.5 Lonza Key News
7.8 New England Biolabs
7.8.1 New England Biolabs Corporate Summary
7.8.2 New England Biolabs Business Overview
7.8.3 New England Biolabs Genome Editing/Genome Engineering Major Product Offerings
7.8.4 New England Biolabs Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.8.5 New England Biolabs Key News
7.9 Origene Technologies
7.9.1 Origene Technologies Corporate Summary
7.9.2 Origene Technologies Business Overview
7.9.3 Origene Technologies Genome Editing/Genome Engineering Major Product Offerings
7.9.4 Origene Technologies Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.9.5 Origene Technologies Key News
7.10 Transposagen Biopharmaceuticals
7.10.1 Transposagen Biopharmaceuticals Corporate Summary
7.10.2 Transposagen Biopharmaceuticals Business Overview
7.10.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Major Product Offerings
7.10.4 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.10.5 Transposagen Biopharmaceuticals Key News
7.11 Editas Medicine
7.11.1 Editas Medicine Corporate Summary
7.11.2 Editas Medicine Business Overview
7.11.3 Editas Medicine Genome Editing/Genome Engineering Major Product Offerings
7.11.4 Editas Medicine Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.11.5 Editas Medicine Key News
7.12 Crispr Therapeutics
7.12.1 Crispr Therapeutics Corporate Summary
7.12.2 Crispr Therapeutics Business Overview
7.12.3 Crispr Therapeutics Genome Editing/Genome Engineering Major Product Offerings
7.12.4 Crispr Therapeutics Genome Editing/Genome Engineering Revenue in Global (2016-2021)
7.12.5 Crispr Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Genome Editing/Genome Engineering Market Opportunities & Trends in Global Market
Table 2. Genome Editing/Genome Engineering Market Drivers in Global Market
Table 3. Genome Editing/Genome Engineering Market Restraints in Global Market
Table 4. Key Players of Genome Editing/Genome Engineering in Global Market
Table 5. Top Genome Editing/Genome Engineering Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Genome Editing/Genome Engineering Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Genome Editing/Genome Engineering Revenue Share by Companies, 2016-2021
Table 8. Global Companies Genome Editing/Genome Engineering Product Type
Table 9. List of Global Tier 1 Genome Editing/Genome Engineering Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genome Editing/Genome Engineering Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Genome Editing/Genome Engineering Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Genome Editing/Genome Engineering Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Genome Editing/Genome Engineering Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, (US$, Mn), 2022-2027
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Genome Editing/Genome Engineering Product Offerings
Table 32. Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Genome Editing/Genome Engineering Product Offerings
Table 35. Merck Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 36. Horizon Discovery Corporate Summary
Table 37. Horizon Discovery Genome Editing/Genome Engineering Product Offerings
Table 38. Horizon Discovery Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 39. Genscript Corporate Summary
Table 40. Genscript Genome Editing/Genome Engineering Product Offerings
Table 41. Genscript Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 42. Sangamo Biosciences Corporate Summary
Table 43. Sangamo Biosciences Genome Editing/Genome Engineering Product Offerings
Table 44. Sangamo Biosciences Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 45. Integrated Dna Technologies Corporate Summary
Table 46. Integrated Dna Technologies Genome Editing/Genome Engineering Product Offerings
Table 47. Integrated Dna Technologies Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 48. Lonza Corporate Summary
Table 49. Lonza Genome Editing/Genome Engineering Product Offerings
Table 50. Lonza Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 51. New England Biolabs Corporate Summary
Table 52. New England Biolabs Genome Editing/Genome Engineering Product Offerings
Table 53. New England Biolabs Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 54. Origene Technologies Corporate Summary
Table 55. Origene Technologies Genome Editing/Genome Engineering Product Offerings
Table 56. Origene Technologies Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 57. Transposagen Biopharmaceuticals Corporate Summary
Table 58. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product Offerings
Table 59. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 60. Editas Medicine Corporate Summary
Table 61. Editas Medicine Genome Editing/Genome Engineering Product Offerings
Table 62. Editas Medicine Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
Table 63. Crispr Therapeutics Corporate Summary
Table 64. Crispr Therapeutics Genome Editing/Genome Engineering Product Offerings
Table 65. Crispr Therapeutics Genome Editing/Genome Engineering Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Genome Editing/Genome Engineering Segment by Type
Figure 2. Genome Editing/Genome Engineering Segment by Application
Figure 3. Global Genome Editing/Genome Engineering Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Genome Editing/Genome Engineering Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Genome Editing/Genome Engineering Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genome Editing/Genome Engineering Revenue in 2020
Figure 8. By Type - Global Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 9. By Application - Global Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 10. By Region - Global Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 11. By Country - North America Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 12. US Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 16. Germany Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 17. France Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 24. China Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 28. India Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 30. Brazil Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue Market Share, 2016-2027
Figure 33. Turkey Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Genome Editing/Genome Engineering Revenue, (US$, Mn), 2016-2027
Figure 37. Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Horizon Discovery Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Genscript Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sangamo Biosciences Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Integrated Dna Technologies Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Lonza Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. New England Biolabs Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Origene Technologies Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Editas Medicine Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Crispr Therapeutics Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated Dna Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics